Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 43
MetricValuePeriodScopeSource row
Revenue¥1.3bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income−¥149m2024-04-01 → 2024-09-30Cons.Operating income
Operating income−¥242m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income−¥103m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥40m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥70m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax−¥103m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥62m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥104m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥31m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥61m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥104m2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥61m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥9.4bnat 2024-09-30Cons.Assets
Total assets¥9.1bnat 2024-03-31Cons.Assets
Total assets¥8.4bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥679mat 2024-09-30Cons.Liabilities
Total liabilities¥741mat 2024-03-31Cons.Liabilities
Net assets / equity¥8.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥8.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥7.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.0bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥2.9bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥3.0bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.9bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥131m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥11m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥58m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥412m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥404m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥46m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥681m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥544m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-1.142024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.372023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥0.712023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio92.8%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio91.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio92.1%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2024-04-01 → 2024-09-30−¥378m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥176m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥8m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥1.1bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2024-04-01 → 2024-09-30¥267m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.3bn
—segment totalsegment ordinary income2024-04-01 → 2024-09-30¥275m
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-09-30−¥214m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥122m
jpcrp040300-q2r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥110m
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.0bn
jpcrp040300-q2r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-09-30¥174m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment ordinary income2023-04-01 → 2023-09-30¥284m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 483
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember1325600
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0140
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1024950
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0108
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember1000000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0106
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember823600
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0087
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember700000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0074
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember647264
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0068
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember598253
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0063
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember508529
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0053
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember500000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0053
Number of shares heldCurrentQuarterInstant8822640
Shareholding ratioCurrentQuarterInstant0.0936
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember104200
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember94198800
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember941988
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember28891
Number of shares issued shares voting rightsCurrentQuarterInstant94331891
Number of voting rights issued shares voting rightsCurrentQuarterInstant941988
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member104200
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member104200
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0011
Number of shares held in own name treasury shares etcCurrentQuarterInstant104200
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant104200
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0011
Cash and depositsPrior1YearInstant2939057000JPY
Cash and depositsCurrentQuarterInstant3046249000JPY
Accounts receivable tradePrior1YearInstant421337000JPY
Accounts receivable tradeCurrentQuarterInstant361714000JPY
Short term investment securitiesPrior1YearInstant3627800000JPY
Short term investment securitiesCurrentQuarterInstant2120780000JPY
Merchandise and finished goodsPrior1YearInstant74234000JPY
Merchandise and finished goodsCurrentQuarterInstant106553000JPY
Work in processPrior1YearInstant58502000JPY
Work in processCurrentQuarterInstant80155000JPY
Raw materials and suppliesPrior1YearInstant115404000JPY
Raw materials and suppliesCurrentQuarterInstant91117000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass